We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults taking NG101 had fewer semaglutide-induced events ...

Most weight loss and diabetes drugs on the market struggle to deliver lasting results. GLP-1 medications like Ozempic and Zepbound work by acting on brain neurons that control hunger. They help ...

A study involving nearly 28,000 people identifies the genes that may influence weight loss with Ozempic and Mounjaro.

WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS™ (tradipitant), an oral ...

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, obesity, or other conditions, according to a KFF Health Tracking poll. But many ...